{"transactions":[{"id":718515,"issuer":{"id":6502,"kind":"organization","name":"ADC Therapeutics SA"},"owners":[{"id":33006,"kind":"person","name":"Zaki Mohamed","position":1,"cik":"0002000697","reported_name":"Zaki Mohamed","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Shares","published_at":"2026-07-02T21:17:13.000Z","date":"2026-06-30","kind":"grant","planned":false,"acquired":true,"shares":213900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of restricted stock units (\"RSUs\") granted on June 30, 2026 pursuant to an incentive award letter agreement. The RSUs will vest upon the earlier of (i) June 30, 2027 or (ii) termination of employment by the Issuer without cause or by the reporting person for good reason, subject to the reporting person's continued employment with the Issuer on the vesting date. Each RSU represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":896317,"source":{"system":"sec-edgar","filing":"0001628280-26-047036","document":"wk-form4_1783027029.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2000697/000162828026047036/wk-form4_1783027029.xml","form_type":"4"}},{"id":897383,"issuer":{"id":6502,"kind":"organization","name":"ADC Therapeutics SA"},"owners":[{"id":33006,"kind":"person","name":"Zaki Mohamed","position":1,"cik":"0002000697","reported_name":"Zaki Mohamed","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Shares","published_at":"2026-02-18T22:43:44.000Z","date":"2026-02-13","kind":"tax_withholding","planned":false,"acquired":false,"shares":24603,"price":3.99,"value":98165.97,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of Common Shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted share units previously granted."}],"balance_after":682417,"source":{"system":"sec-edgar","filing":"0001628280-26-009282","document":"wk-form4_1771454620.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2000697/000162828026009282/wk-form4_1771454620.xml","form_type":"4"}},{"id":897382,"issuer":{"id":6502,"kind":"organization","name":"ADC Therapeutics SA"},"owners":[{"id":33006,"kind":"person","name":"Zaki Mohamed","position":1,"cik":"0002000697","reported_name":"Zaki Mohamed","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Shares","published_at":"2026-02-18T22:43:44.000Z","date":"2026-02-13","kind":"grant","planned":false,"acquired":true,"shares":285200,"price":3.99,"value":1137948.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Common Shares to be delivered in settlement of a restricted share unit award which vests one-third on the first anniversary of the grant date, which grant date is February 13, 2026, and then one-third on each anniversary date thereafter, upon continued service through the designated vesting event."}],"balance_after":707020,"source":{"system":"sec-edgar","filing":"0001628280-26-009282","document":"wk-form4_1771454620.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2000697/000162828026009282/wk-form4_1771454620.xml","form_type":"4"}},{"id":976383,"issuer":{"id":6502,"kind":"organization","name":"ADC Therapeutics SA"},"owners":[{"id":33006,"kind":"person","name":"Zaki Mohamed","position":1,"cik":"0002000697","reported_name":"Zaki Mohamed","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Shares","published_at":"2025-12-09T22:09:56.000Z","date":"2025-12-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":41068,"price":3.29,"value":135113.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of Common Shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted share units previously granted."},{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"Represents the number of Common Shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted share units previously granted."}],"balance_after":421820,"source":{"system":"sec-edgar","filing":"0001628280-25-056171","document":"wk-form4_1765318192.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2000697/000162828025056171/wk-form4_1765318192.xml","form_type":"4"}},{"id":1267688,"issuer":{"id":6502,"kind":"organization","name":"ADC Therapeutics SA"},"owners":[{"id":33006,"kind":"person","name":"Zaki Mohamed","position":1,"cik":"0002000697","reported_name":"Zaki Mohamed","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Shares","published_at":"2025-02-14T23:22:49.000Z","date":"2025-02-13","kind":"grant","planned":false,"acquired":true,"shares":230000,"price":1.61,"value":370300.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Common Shares to be delivered in settlement of a restricted share unit award which vests one-third on the first anniversary of the grant date, which grant date is February 13, 2025, and then one-third on each anniversary date thereafter, upon continued service through the designated vesting event."}],"balance_after":462888,"source":{"system":"sec-edgar","filing":"0001628280-25-005862","document":"wk-form4_1739575362.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2000697/000162828025005862/wk-form4_1739575362.xml","form_type":"4"}},{"id":1339242,"issuer":{"id":6502,"kind":"organization","name":"ADC Therapeutics SA"},"owners":[{"id":33006,"kind":"person","name":"Zaki Mohamed","position":1,"cik":"0002000697","reported_name":"Zaki Mohamed","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Shares","published_at":"2024-12-10T01:42:48.000Z","date":"2024-12-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":37112,"price":3.13,"value":116160.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of Common Shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted share units previously granted."},{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"Represents the number of Common Shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted share units previously granted."}],"balance_after":232888,"source":{"system":"sec-edgar","filing":"0001628280-24-050543","document":"wk-form4_1733794961.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2000697/000162828024050543/wk-form4_1733794961.xml","form_type":"4"}}]}